Reviewed by Michael Gill, B. Sc.
25 Diabetes Type 2 Clinical Trials Near Me
Top Hospitals for Diabetes Type 2 Clinical Trials
Image of Novo Nordisk Investigational Site in California.
Novo Nordisk Investigational Site
Los Angeles
11Active Trials
55All Time Trials for Diabetes Type 2
2002First Diabetes Type 2 Trial
Image of Novo Nordisk Investigational Site in Texas.
Novo Nordisk Investigational Site
San Antonio
11Active Trials
83All Time Trials for Diabetes Type 2
2001First Diabetes Type 2 Trial
Top Cities for Diabetes Type 2 Clinical Trials
Diabetes Type 2 Clinical Trials by Phase of Trial
Phase < 1 Diabetes Type 2 Clinical Trials
2Active Diabetes Type 2 Clinical Trials
2Number of Unique Treatments
2Number of Active Locations
Intralipid, 20% Intravenous EmulsionGoldenseal (Hydrastis canadensis)
Diabetes Type 2 Clinical Trials by Age Group
< 18 Diabetes Type 2 Clinical Trials
4Active Diabetes Type 2 Clinical Trials
AfrezzaFit 24Canagliflozin 300 mgEmpagliflozin
Top Treatments for Diabetes Type 2 Clinical Trials
Treatment Name
Active Diabetes Type 2 Clinical Trials
All Time Trials for Diabetes Type 2
First Recorded Diabetes Type 2 Trial
Semaglutide
9
48
2017
Community Health Navigator Program
3
3
2021
Dapagliflozin
3
106
2006
IcoSema
3
4
2021
Oral semaglutide
3
13
2019
Recently Completed Studies with FDA Approved Treatments for Diabetes Type 2
Treatment
Year
Sponsor
Insulin icodec
2022
Novo Nordisk A/S
LY3502970
2021
Eli Lilly and Company
Finerenone (BAY94-8862)
2021
Bayer
Cagrilintide 2.4 mg
2021
Novo Nordisk A/S
Insulin icodec
2021
Novo Nordisk A/S
LY3437943
2021
Eli Lilly and Company
Botox 200 UNT Injection
2021
Vanderbilt University Medical Center
Insulin icodec
2021
Novo Nordisk A/S
Insulin Icodec
2021
Novo Nordisk A/S
PF-06882961 20 mg
2021
Pfizer

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 14th, 2021

Last Reviewed: November 24th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.